Pub. Date : 2006 Jun
PMID : 16774472
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Systemic administration of the 3-hydroxyanthranilate-3,4-dioxygenase (3-HAD) inhibitor, 4-chloro-3-hydroxyanthranilate (4Cl-3HAA; approximately 100 mg/kg every 12 h, beginning 5 h after injury) attenuated local QUIN production and reduced QUIN accumulation at the site of injury by approximately 50% at day 12, without enhanced accumulations of the neuroprotective metabolite kynurenic acid (KYNA). | Kynurenic Acid | 3-hydroxyanthranilate 3,4-dioxygenase | Cavia porcellus |